ClinicalTrials.Gov Shows which Trials have been done using NBMI, and which haven’t started

https://clinicaltrials.gov/search?intr=nbmi&viewType=Table

–

https://clinicaltrials.gov/search?intr=irminix&viewType=Table

See also https://www.youtube.com/@Evidenceofharm/videos

Full Movie: https://evidence-of-harm.com/

https://clinicaltrials.gov/study/NCT04183595

Status d.d. 2024-02-03: Not Yet Recruiting

The clinicaltrials website lists the following status’

• Not yet recruiting: The study has not started recruiting participants.
• Recruiting: The study is currently recruiting participants.
• Enrolling by invitation: The study is selecting its participants from a population, or group of people, decided on by the researchers in advance. These studies are not open to everyone who meets the eligibility criteria but only to people in that particular population, who are specifically invited to participate.
• Active, not recruiting: The study is ongoing, and participants are receiving an intervention or being examined, but potential participants are not currently being recruited or enrolled.
• Suspended: The study has stopped early but may start again.
• Terminated: The study has stopped early and will not start again. Participants are no longer being examined or treated.
• Completed: The study has ended normally, and participants are no longer being examined or treated (that is, the last participant’s last visit has occurred).
• Withdrawn: The study stopped early, before enrolling its first participant.
• Unknown: A study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been last verified within the past 2 years.****

Study Status

• Record Verification| 2024-03
• Overall Status | Recruiting
• Study Start | 2023-11-22 [Actual]
• Primary Completion | 2024-05-22 [Estimated]
• Study Completion | 2024-11-22 [Estimated]
• First Submitted | 2019-06-19
• First Submitted that Met QC Criteria | 2019-11-28
• First Posted | 2019-12-03
• Last Update Submitted that Met QC Criteria | 2024-03-08
• Last Update Posted | 2024-03-12 [Actual]

Last changes:

• Recruitment Status
• Study Status
• Contacts/Locations

https://emeramed.com/study-mercury-poisoned-gold-miners/

Emeramide found to be safe and effective

This study would indicate that Emeramide is both safe and effective at chelating mercury and thereby reducing the symptoms associated with mercury exposure. In addition to environmental exposure, there are a great many products that still contain mercury and those exposed would likely benefit greatly from a similar round of treatment.

To read the published study, click here:

Efficacy of N,N‘bis-(2-mercaptoethyl) isophthalamide on mercury intoxication: a randomized controlled trial Published: 14 February 2018